The new program centralizes comparator sourcing, compliance documentation, and trial-specific logistics into a single operational framework, allowing clinical research organizations to reduce ...
Feb 10 (Reuters) - The U.S. Food and Drug Administration will not review Moderna's (MRNA.O), opens new tab approval application for its influenza vaccine, the company said on Tuesday, sending its ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
SAN FRANCISCO and SUZHOU, China, Jan. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than Genentech’s Vabysmo for patients with diabetic macular edema (DME) in an early ...
KAWASAKI, Japan--(BUSINESS WIRE)--Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched a CMOS dual comparator, "TC75W71FU." It features a high-speed response and a full ...
Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched a CMOS dual comparator, "TC75W71FU." It features a high-speed response and a full input/output range (Rail to Rail), suiting ...
The SURPASS-CVOT trial—the large cardiovascular outcomes study that showed tirzepatide (Mounjaro) compared favorably with dulaglutide (Trulicity; both Eli Lilly) in patients with type 2 diabetes and ...
In New York, comparator evidence is common in discrimination cases but rarely used in employment contract disputes. Courts look at whether similarly situated employees were treated differently, often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results